Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Regeneron Pharmaceuticals' Depreciation & Amortization (CF) came in at $123.7 million for Q2 2026, down 8.4% from $135.1 million a year earlier but up 0.4% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Regeneron Pharmaceuticals reported Depreciation & Amortization (CF) of $528.6 million, up 3.6% year-over-year; for FY2025, it came in at $543.7 million, up 12.6% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last 16 years, with a five-year compound annual growth rate of 18.2% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $482.9 million in FY2024 (+14.7%), $421 million in FY2023 (+23.3%), $341.4 million in FY2022 (+19.3%) and $286.2 million in FY2021 (+21.3%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $73.2 million (Q3 2021) to $145 million (Q4 2025).
  • Year-over-year, Depreciation & Amortization (CF) increased in six of the last eight quarters, with growth averaging 8.3%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2023 (growth of 38.6%), and the weakest in Q2 2026 (a decline of 8.4%).
  • Business Quant data shows REGN's Depreciation & Amortization (CF) at $123.2 million (Q1 2026), $145 million (Q4 2025) and $136.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 1.96 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 194.00 Mn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 1.93 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 98.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 1.62 Bn
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 123.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 123.70 Mn
Mar 31, 2026 123.20 Mn
Dec 31, 2025 145.00 Mn
Sep 30, 2025 136.70 Mn
Jun 30, 2025 135.10 Mn
Mar 31, 2025 126.90 Mn
Dec 31, 2024 126.40 Mn
Sep 30, 2024 121.70 Mn
Jun 30, 2024 120.70 Mn
Mar 31, 2024 114.10 Mn
Dec 31, 2023 113.00 Mn
Sep 30, 2023 105.40 Mn
Jun 30, 2023 103.10 Mn
Mar 31, 2023 99.50 Mn
Dec 31, 2022 100.10 Mn
Sep 30, 2022 92.60 Mn
Jun 30, 2022 74.40 Mn
Mar 31, 2022 74.30 Mn
Dec 31, 2021 74.50 Mn
Sep 30, 2021 73.20 Mn
API Access

Regeneron Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=REGN&period=max&api_key=YOUR_API_KEY